NCT00041015View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

November 30, 2002

Study Completion Date

November 30, 2002

Conditions
Lung Cancer
Interventions
DRUG

cisplatin

DRUG

etoposide

DRUG

topotecan hydrochloride

Trial Locations (1)

44106-5065

Ireland Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Case Comprehensive Cancer Center

OTHER

NCT00041015 - Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter